This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
JD Amsterdam , J Shults (2010 a). Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode. Journal of Clinical Psychopharmacology 30, 306–311.
JD Amsterdam , J Shults (2010 b). Efficacy and safety of long-term fluoxetine vs. lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. The American Journal of Psychiatry 167, 792–800.
J Angst , A Gamma , F Benazzi , B Silverstein , (2006). Atypical depressive syndromes in varying definitions. European Archives of Psychiatry and Clinical Neuroscience 256, 44–54.
JS Ballon , D Feifel (2006). A systematic review of modafinil: Potential clinical uses and mechanisms of action. Journal of Clinical Psychiatry 67, 554–566.
J Bannet , RP Ebstein , RH Belmaker (1980). Clinical aspects of the interaction of lithium and stimulants. British Journal of Psychiatry 136, 204.
JV Baranski , R Pigeau , P Dinich , I Jacobs (2004). Effects of modafinil on cognitive and meta-cognitive performance. Human Psychopharmacology 19, 323–332.
RH Belmaker (2007). Modafinil add-on in the treatment of bipolar depression. American Journal of Psychiatry 164, 1143–1145.
E Bora , M Yucel , C Pantelis (2009). Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. Journal of Affective Disorders 113, 1–20.
E Bora , M Yücel , C Pantelis , M Berk (2011). Meta-analytic review of neurocognition in bipolar II disorder. Acta Psychiatrica Scandinavica 123, 165–174.
JR Calabrese , TA Ketter , JM Youakim , JM Tiller , (2010). Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study. Journal of Clinical Psychiatry 71, 1363–1370.
A Camacho , B Ng (2006). Methylphenidate for alpha-interferon induced depression. Journal of Psychopharmacology 20, 687–689.
A Camacho , B Ng , MA Frye (2010). Modafinil for bipolar depression with comorbid methamphetamine abuse. American Journal of Addictions 19, 190–191.
PJ Carlson , MC Merlock , T Suppes (2004). Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation. Bipolar Disorders 6, 416–420.
B Chavez , MA Sopko , MJ Ehret , RE Paulino , (2009). An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder. Annals of Pharmacotherapy 43, 1084–1095.
RJ Chiarello , JO Cole (1987). The use of psychostimulants in general psychiatry. A reconsideration. Archives of General Psychiatry 44, 286–295.
D Cicero , RS El-Mallakh , J Holman , J Robertson (2003). Antidepressant exposure in bipolar children. Psychiatry 66, 317–322.
KR Connolly , ME Thase (2011). If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. Drugs 71, 43–64.
CA Czeisler , JK Walsh , T Roth , RJ Hughes , (2005). U. S. Modafinil in Shift Work Sleep Disorder Study Group. Modafinil for excessive sleepiness associated with shift-work sleep disorder. New England Journal of Medicine 353, 476–486.
E Davidoff , EC Reifenstein (1939). The results of eigtheen months of benzedrine sulfate therapy in Psychiatry. American Journal of Psychiatry 95, 945–969.
C DeBattista , K Doghramji , MA Menza , MH Rosenthal , (2003) Modafinil in Depression Study Group. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. Journal of Clinical Psychiatry 64, 1057–1064.
MP DelBello , CA Soutullo , W Hendricks , RT Niemeier , (2001). Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset. Bipolar Disorders 3, 53–57.
JE De Séréville , C Boer , FA Rambert , J Duteil (1994). Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vivo voltammetry studies. Neuropharmacology 33, 755–761.
RS El-Mallakh (2000). An open study of methylphenidate in bipolar depression. Bipolar Disorders 2, 56–59.
M Fava , ME Thase , C DeBattista (2005). A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. Journal of Clinical Psychiatry 66, 85–93.
J Fawcett , HM Kravitz , JM Zajecka , MR Schaff (1991). CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression. Journal of Clinical Psychopharmacology 11, 127–132.
SS Feinberg (2004). Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication. Journal of Clinical Psychiatry 65, 1520–1524.
PP Fernandes , F Petty (2003). Modafinil for remitted bipolar depression with hypersomnia. Annals of Pharmacotherapy 37, 1807–1809.
RL Findling , EJ Short , NK McNamara , CA Demeter , (2007). Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 46, 1445–1453.
KN Fountoulakis , M Siamouli , P Panagiotidis , S Magiria (2008). Ultra short manic-like episodes after antidepressant augmentation with modafinil. Progress in Neuropsychopharmacol & Biological Psychiatry 32, 891–892.
MA Frye , H Grunze , T Suppes , SL McElroy , (2007). A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. American Journal of Psychiatry 164, 1242–1249.
SN Ghaemi , DJ Hsu , F Soldani , FK Goodwin (2003). Antidepressants in bipolar disorder: the case for caution. Bipolar Disorders 5, 421–433.
JF Goldberg , KN Chengappa (2009). Identifying and treating cognitive impairment in bipolar disorder. Bipolar Disorders 11 (Suppl. 2), 123–137.
HC Grunze (2008). Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation? CNS Spectrum 13, 790–795.
H Grunze , E Vieta , GM Goodwin , C Bowden , (2010). WFSBP task force on treatment guidelines for bipolar disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World Journal of Biological Psychiatry 11, 81–109.
M Hamilton (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23, 56–62.
CC Huang , IS Shiah , HK Chen , WC Mao , (2008). Adjunctive use of methylphenidate in the treatment of psychotic unipolar depression. Clinical Neuropharmacology 31, 245–247.
LL Judd , HS Akiskal , PJ Schettler , J Endicott (2002). The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry 59, 530–537.
LL Judd , PJ Schettler , DA Solomon , JD Maser , (2008). Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders. Journal of Affective Disorders 108, 49–58.
RW Kupka , LL Altshuler , WA Nolen , T Suppes , (2007). Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disorders 9, 531–535.
JS Lin , B Roussel , H Akaoka , P Fort , (1992). Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Research 591, 319–326.
E Lydon , RS El-Mallakh (2006). Naturalistic long-term use of methylphenidate in bipolar disorder. Journal of Clinical Psychopharmacology 26, 516–518.
JS Markowitz , SD Morrison , CL DeVane (1999). Drug interactions with psychostimulants. International Clinical Psychopharmacology 14, 1–18.
P Masand , P Pickett , GB Murray (1991). Psychostimulants for secondary depression in medical illness. Psychosomatics 32, 203–208.
MA Menza , KR Kaufman , A Castellanos (2000). Modafinil augmentation of antidepressant treatment in depression. Journal of Clinical Psychiatry 61, 378–381.
KR Merikangas , HS Akiskal , J Angst , PE Greenberg , (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Archives of General Psychiatry 64, 543–552.
MJ Minzenberg , CS Carter (2008). Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33, 1477–1502.
PB Mitchell , GM Goodwin , GF Johnson , RM Hirschfeld (2008). Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disorders 10, 144–152.
PB Mitchell , K Wilhelm , G Parker , MP Austin , (2001). The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. Journal of Clinical Psychiatry 62, 212–216.
SA Montgomery , M Åsberg (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382–389.
S Morein-Zamir , DC Turner , BJ Sahakian (2007). A review of the effects of modafinil on cognition in schizophrenia. Schizophrenia Bulletin 33, 1298–1306.
S Nasr (2004). Modafinil as adjunctive therapy in depressed outpatients. Annals of Clinical Psychiatry 16, 133–138.
S Nasr , B Wendt , K Steiner (2006). Absence of mood switch with and tolerance to modafinil: a replication study from a large private practice. Journal of Affective Disorders 95, 111–114.
K Orr , D Taylor (2007). Psychostimulants in the treatment of depression: a review of the evidence. CNS Drugs 21, 239–257.
G Parker , H Brotchie (2010). Do the old psychostimulant drugs have a role in managing treatment-resistant depression? Acta Psychiatrica Scandinavica 121, 308–314.
AA Patkar , PS Masand , CU Pae , K Peindl , (2006). A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. Journal of Clinical Psychopharmacology 26, 653–656.
RH Perlis , MJ Ostacher , R Uher , AA Nierenberg , (2009). Stability of symptoms across major depressive episodes in bipolar disorder. Bipolar Disorders 11, 867–875.
DT Plante (2008). Treatment-emergent hypomania or mania with modafinil. American Journal Psychiatry 165, 134–135.
RM Post , KD Denicoff , GS Leverich , LL Altshuler , (2003). Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. Journal of Clinical Psychiatry 64, 680–690.
CG Reichart , WA Nolen (2004). Earlier onset of bipolar disorder in children by antidepressants or stimulants? An hypothesis. Journal of Affective Disorders 78, 81–84.
D Repantis , P Schlattmann , O Laisney , I Heuser (2010). Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacological Research 62, 187–206.
RB Rosse , SK Johri , SI Deutsch (1997). Pupillary changes associated with the development of stimulant-induced mania: a case report. Clinical Neuropharmacology 20, 270–275.
HB Rothenhäusler , S Ehrentraut , G von Degenfeld , M Weis , (2000). Treatment of depression with methylphenidate in patients difficult to wean from mechanical ventilation in the intensive care unit. Journal of Clinical Psychiatry 61, 750–755.
M Rozans , A Dreisbach , JJ Lertora , MJ Kahn (2002). Palliative uses of methylphenidate in patients with cancer: a review. Journal of Clinical Oncology 20, 335–339.
AJ Rush , DE Giles , MA Schlesser , CL Fulton , (1986). The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Research 18, 65–87.
JL Schaller , D Behar (1998). Treatment of a case of comorbid bipolar disorder and attention-deficit/hyperactivity disorder. Journal of Neuropsychiatry and Clinical Neurosciences 10, 235–236.
RE Scheffer , RA Kowatch , T Carmody , AJ Rush (2005). Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. American of Journal Psychiatry 162, 58–64.
P Schoenknecht , S Olbrich , C Sander , P Spindler , (2010). Treatment of acute mania with modafinil monotherapy. Biological Psychiatry 67, e55–e57.
RC Shelton , R Reddy (2008). Adjunctive use of modafinil in bipolar patients: just another stimulant or not? Current Psychiatry Reports 10, 520–524.
B Shopsin , S Gershon (1978). Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495). Neuropsychobiology 4, 1–14.
CA Soutullo , MP DelBello , JE Ochsner , SL McElroy , (2002). Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment. Journal of Affective Disorders 70, 323–327.
MK Spearing , RM Post , GS Leverich , D Brandt , (1997). Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Research 73, 159–171.
D Sulzer , MS Sonders , NW Poulsen , A Galli (2005). Mechanisms of neurotransmitter release by amphetamines: a review. Progress in Neurobiology 75, 406–433.
M Tohen , TG Jacobs , PD Feldman (2000). Onset of action of antipsychotics in the treatment of mania. Bipolar Disorders 2, 261–268.
L Tondo , G Isacsson , R Baldessarini (2003). Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs 17, 491–511.
DC Turner , L Clark , J Dowson , TW Robbins , (2004 b). Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biological Psychiatry 55, 1031–1040.
DC Turner , L Clark , E Pomarol-Clotet , P McKenna , (2004 a). Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29, 1363–1373.
DB Yates , S Dittmann , F Kapczinski , CM Trentini (2011). Cognitive abilities and clinical variables in bipolar I depressed and euthymic patients and controls. Journal of Psychiatric Research 45, 495–504.
LN Yatham , SH Kennedy , A Schaffer , SV Parikh , (2009). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders 11, 225–255.